Dr. Mary John Ninan, MD

Dr. Ninan practices at Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital.

Dr. Ninan's NPI, 1356533145, was assigned on August 15, 2007. Dr. Ninan holds Georgia license 058551.

Dr. Ninan's primary practice is Northside Hospital Atlanta, at 1000 Johnson Ferry Road, NE, Atlanta, GA 30342 in Fulton County. The practice phone is (404) 851-8000.

Dr. Ninan's primary practice is Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital. Dr. Ninan is also affiliated with Northside Hospital Forsyth. The medical group on file is City of Hope Atlanta. Dmand AI also links Dr. Ninan to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ninan practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ninan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Ninan's licenses on file in 2 states: Georgia and Texas.

CMS data shows 497 Medicare services from Dr. Ninan across 8 procedure codes in 2024, for 201 Medicare patients. Medicare paid $31,942 for them.

CMS counts 201 Medicare patients who saw Dr. Ninan in 2024. The largest group is 75 to 84, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ninan's median patient age at 63, with 70% women.

In 2024, Dr. Ninan wrote 532 Medicare Part D claims for 88 patients. 67% of them were for generic drugs. CMS names the drug for 354 of them, across 14 drugs with 11 or more claims each, at $1,328,283 in total drug cost. In 2023, CMS named 332 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Ninan for performance year 2024, reported as part of a group. Dr. Ninan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ninan as offering telehealth.

Dmand AI links 7 papers to Dr. Ninan, published from 2011 to 2014. The most frequent topics are Rituximab, Antibodies, Monoclonal, Murine-Derived and Antineoplastic Agents. Dr. Ninan's most frequent co-authors are Pankaj Gupta, MD, Bagi Rp Jana, MD and Avi Bart Markowitz, MD.

Dmand AI links Dr. Ninan to 1 clinical trial. Conditions studied include Neoplasm Metastasis and Neoplastic Processes.

CMS Open Payments shows 241 general payments to Dr. Ninan from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. ADC Therapeutics America, Inc. paid the most, $2,400.